Transition At IP-Watch: A New Path Forward 25/03/2019 by Intellectual Property Watch, Intellectual Property Watch 2 Comments Dear Readers, After 15 years of original, independent, thoughtful, and timely reporting on global policymaking from the inside, Intellectual Property Watch (IP-Watch) is announcing today a pause on reporting services as it embarks on a transition phase to devise new strategies for future work.
Health Policy Watch – Continuing The IP-Watch Tradition Of Vibrant Health Reporting 25/03/2019 by Intellectual Property Watch, Intellectual Property Watch Leave a Comment Following today’s announcement of a one-year pause on IP-Watch reporting, we invite all IP-Watch readers to sign up here for free daily, weekly or monthly news bulletins from our sister publication, Health Policy Watch, which will include health-related IP reporting as part of its portfolio. You can follow Health Policy Watch (www.healthpolicy-watch.org) on Twitter @HealthPolicyW.
South Africa Moves Forward With Creator Rights Agenda 21/03/2019 by Intellectual Property Watch 5 Comments Prof. Sean Flynn writes: The South Africa National Council of Provinces has cleared the Copyright Amendment Bill for a final vote. The bill would adopt an innovative fair use right as well as new rights of creators to receive royalties, partially own commissioned works, protect works through technological protections (with exceptions for fair use), establish of a tribunal for lower cost enforcement and regulate collective management companies. It establishes what is being referred to as a creator rights model for copyright reform including rights to create, own and earn.
WIPO Election: Who Will Run To Be The Next Director General? 18/03/2019 by William New, Intellectual Property Watch Leave a Comment The decision is a year away, but there has been buzz for months around who might run in the election to be the next director general of the World Intellectual Property Organization. Intellectual Property Watch shares with you some of the names we’ve heard in the early going, completely unofficially and in no way intended to be exhaustive.
Max Planck Institute Director Reto Hilty: Europe Might Miss Chance For Real Copyright Law Modernization 16/03/2019 by Monika Ermert for Intellectual Property Watch 2 Comments With the final vote over Europe’s new copyright directive being expected during the Parliament’s March 26th session in Strasbourg, two decades of the copyright wars seem to culminate in another hot battle. Thousands of citizens have taken to the streets during recent weeks warning that the intended changes to liability fundamentally change how citizens can use social media platforms in the future. Article 13 will make providers liable for any copyright violation, pushing them to automatically filter content uploaded by their users. Article 11, the so-called snippet law or link tax, has been pushed for by large publishers in order to compel Google and the likes to share their revenues. Amidst the ongoing fight, Reto Hilty, Director of the Max Planck Institute for Innovation and Competition (MPI) in Munich, took a cool, analytic look into the two most debated provisions and concludes that the reform–even after a number of amendments – misses on what it originally set out to achieve: adapting copyright to digital times. [Note: this interview by IP-Watch writer Monika Ermert first appeared in German in heise online, hereheise online, here.]
Summaries Of The Recent US Supreme Court Copyright Decisions: Finnegan LLP 07/03/2019 by William New, Intellectual Property Watch 1 Comment The United States Supreme Court took two important actions on copyright-related matters this week. US law firm Finnegan LLP has summarised the decisions in two separate articles.
2019 Medicines For Europe Legal Affairs Conference 07/03/2019 by Intellectual Property Watch, Intellectual Property Watch 1 Comment Advertisement: The 2019 Medicines for Europe Legal Affairs Conference will take place, for the first time, in Amsterdam. In its 15th edition, this conference will provide participants with the opportunity to exchange views and share ideas with leading industry executives and experts, counsel and European institution officials around the latest developments in intellectual property and legal affairs concerning generic, biosimilar and value added medicines within Europe and worldwide.
Chinese IP Officials Complete Study Of UK, European IP Law 06/03/2019 by Intellectual Property Watch Leave a Comment A cohort of senior Chinese officials from the China National Intellectual Property Administration (CNIPA) has graduated from a four-month training programme at the Intellectual Property Research Institute of Queen Mary University of London.
In US, No Remedies For Growing IP Infringements 04/03/2019 by Steven Seidenberg for Intellectual Property Watch Leave a Comment Ubi Jus Ibi Remedium. Alas, that longstanding legal principle – where there’s a right, there’s a remedy – doesn’t apply to IP owners in the US. Thanks to several Supreme Court rulings interpreting the US Constitution, owners of patents have no recourse when their IP is infringed by US states. Copyright owners now face the same fate, unless the Supreme Court reverses a recent 4th Circuit decision.
USTR Reports On 2018, Lays Out IP Priorities For 2019; China A Main Target 04/03/2019 by William New, Intellectual Property Watch Leave a Comment The Office of the United States Trade Representative has issued its annual report on trade relations with other nations, essentially a report on progress and problems from last year and an agenda for what’s coming this year. Multilateral approaches came in for touch criticism, and on intellectual property rights, a vigorous, repeated focus is China.